Limited coverage drugs – nabumetone

Last updated on September 26, 2024

Generic name

nabumetone

Strength

500 mg

Form

tablet

Special Authority criteria

Approval period

For the treatment of patients who have a:

  • Diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout or lupus

OR

  • Treatment failure on optimal doses of, or intolerance to, all of the following: ibuprofen, naproxen, diclofenac AND either celecoxib or meloxicam.

Indefinite

Practitioner exemptions

  • Paediatrics
  • Paediatric cardiology
  • Paediatric general surgery
  • Physical medicine and rehabilitation
  • Rheumatology

Special notes

  • Treatment failure on or intolerance to the specific medications listed in the above criteria is required. Treatment failure on, or intolerance to, the following NSAIDs is not sufficient: ketorolac, mefenamic acid, diclofenac potassium, naproxen sodium.

Special Authority request form(s)